Ignite Creation Date:
2025-12-24 @ 3:59 PM
Ignite Modification Date:
2026-03-09 @ 1:59 AM
Study NCT ID:
NCT00102466
Status:
COMPLETED
Last Update Posted:
2020-12-17
First Post:
2005-01-29
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Vildagliptin Compared to Gliclazide in Combination With Metformin in Patients With Type 2 Diabetes
Sponsor:
Novartis Pharmaceuticals
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2005-01
Start Date Type:
None
Primary Completion Date:
2009-01
Primary Completion Date Type:
ACTUAL
Completion Date:
2009-01
Completion Date Type:
ACTUAL
First Submit Date:
2005-01-29
First Submit QC Date:
None
Study First Post Date:
2005-01-31
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
2013-01-04
Disp First Post Date Type:
ESTIMATED
Last Update Submit Date:
2020-12-11
Last Update Post Date:
2020-12-17
Last Update Post Date Type:
ACTUAL